Sequence analysis of the S gene of recombinant MHV-2/A59 coronaviruses reveals three candidate mutations associated with demyelination and hepatitis

References

• Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL (1984). Murine hepatitis virus-4 (strain JHM)-induced neuro-logic disease is modulated in vivo by monoclonal an-tibody. Virology 132: 261–270.
   PubMed Web of Science ®Google Scholar
• Cavanagh D (1997). Nidovirales: A new order comprising Coronaviridae and Arteriviridae. Arch Virol 142: 629–633.
   PubMed Web of Science ®Google Scholar
• Collins AR, Knobler RL, Powell H, Buchmeier MJ (1982). Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell—cell fusion. Virology 119: 358–371.
   PubMed Web of Science ®Google Scholar
• Dalziel RG, Lampert PW, Talbot PJ, Buchmeier MJ (1986). Site specific alteration of murine hepatitis virus type 4 peplomer glycoprotein S results in reduced neuroviru-lence. I Virol 59: 463–471.
   Google Scholar
• Das Sarma J, Fu L, Hingley ST, Lavi E (2001). Mouse hep-atitis virus type-2 infection in mice: An experimental model system of acute meningitis and hepatitis. Exp Mol Pathol 71: 1–12.
   Google Scholar
• Das Sarma J, Fu L, Tsai JC, Weiss SR, Lavi E (2000). Demyelination determinants map to the spike glycopro-tein gene of coronavirus mouse hepatitis virus. I Virol 74: 9206–9213.
   PubMed Web of Science ®Google Scholar
• Fleming JO, Shubin RA, Sussman MA, Casteel N, Stohlman SA (1989). Monoclonal antibodies to the matrix (El) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168: 162–167.
   PubMed Web of Science ®Google Scholar
• Gallagher TM, Escarmis C, Buchmeier MJ (1991). Alter-ation of the pH dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein. J Virol 65: 1916–1928.
   Google Scholar
• Hingley ST, Gombold JL, Lavi E, Weiss SR (1994). MHV-A59 fusion mutants are attenuated and display altered hepatotropism. Virology 200: 1–10.
   PubMed Web of Science ®Google Scholar
• Hirano N, Fujiwara K, Hino S, Matumoto M (1974). Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch Ges Virusfors 44: 298–302.
   Google Scholar
• Hirano N, Murakami T, Taguchi F, Fujiwara K, Matumoto M (1981). Comparison of mouse hepatitis virus strains for pathogenicity in weanling mice infected by various routes. Arch Virol 70: 69–73.
   Google Scholar
• Houtman JJ, Fleming JO (1996). Pathogenesis of mouse hepatitis virus-induced demyelination. I NeuroVirol 2: 361–376.
   PubMed Web of Science ®Google Scholar
• Keck JG, Soe LH, Makino S, Stohlman SA, Lai MMC (1988). RNA recombination of murine coronavirus: Re-combination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. I Virol 62: 1989–1998.
   Google Scholar
• Knobler RL, Haspel MV, Oldstone MBA (1981). Mouse hepatitis virus type 4 OHM strain)-induced fatal central nervous system disease, part 1 (genetic control and the murine neurone as the susceptible site for disease). I Exp Med 153: 832–843.
   Google Scholar
• Knobler RL, Tunison LA, Lampert PW, Oldstone MBA (1982). Selected mutants of mouse hepatitis virus type 4 OHM strain) induce different CNS diseases. Pathobi-ology of disease induced by wild type and mutants ts8 and ts15 in BALB/c and SJL/J mice. Am I Pathol 109: 157–168.
   Google Scholar
• Lai MMC, Cavanagh D (1997). The molecular biology of coronaviruses. Adv Virus Res 48: 1–100.
   PubMed Web of Science ®Google Scholar
• Laude H, Gelfi J, Lavenant L, Charley B (1992). Single amino acid changes in the viral glycoprotein M affect induction of interferon by the coronavirus transmissible gastroenteritis virus. I Virol 66: 743–749.
   PubMedGoogle Scholar
• Lavi E, Fishman SP, Highkin MK, Weiss SR (1988). Limbic encephalitis following inhalation of murine coronavirus MHV-A59. Lab Invest 58: 31–36.
   Google Scholar
• Lavi E, Gilden DH, Highkin MK, Weiss SR (1986). The or-gan tropism of mouse hepatitis virus A59 is dependent on dose and route of inoculation. Lab Anim Sci 36: 130–135.
   Google Scholar
• Lavi E, Gilden DH, Wroblewska Z, Rorke LB, Weiss SR (1984). Experimental demyelination produced by the A 59 strain of mouse hepatitis virus. Neurology 34: 597–603.
   Google Scholar
• Lavi E, Haluskey JA, Masters PS (1998a). Targeted re-combination between MHV-2 and MHV-A59 to study neurotropic determinants of MHV. Adv Exp Med Biol 440: 543–547.
   Google Scholar
• Lavi E, Kuo L, Haluskey JA, Masters PS (1998b). The pathogenesis of MHV nucleocapsid gene chimeric viruses. Adv Exp Med Biol 440: 537–541.
   Google Scholar
• Lavi E, Murray EM, Makino S, Stohlman SA, Lai MM, Weiss SR (1990). Determinants of coronavirus MHV pathogenesis are localized to 3' portions of the genome as determined by ribonucleic acid-ribonucleic acid recombination. Lab Invest 62: 570–578.
   Google Scholar
• Lavi E, Schwartz T, Jin YP, Fu L (1999). Nidovirus infec-tions: Experimental model systems of human neurologic diseases. J Neuropathol Exp Neurol 58: 1197–1206.
   Google Scholar
• Lavi E, Weiss SR (1989). Coronaviruses. In: Clinical and molecular aspects of neurotropic viral infec-tions. Gilden DH, Lipton HL (eds). Kluwer Academic Publishers: Boston, Massachusetts, pp 101–139.
   Google Scholar
• Leparc-Goffart I, Hingley ST, Chua M-M, Jiang X, Lavi E, Weiss SR (1997). Altered pathogenesis phenotypes of murine coronavirus MHV-A59 are associated with a Q159L amino acid substitution in the receptor binding domain of the spike protein. Virology 239: 1–10.
   Google Scholar
• Leparc-Goffart I, Hingley ST, Chua MM, Phillips J, Lavi E, Weiss SR (1998). Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. I Virol 72: 9628–9636.
   PubMed Web of Science ®Google Scholar
• Navas S, Seo S, Chua MM, Das Sarma J, Lavi E, Hingley ST, Weiss SR (2001). The spike protein of murine coro-navirus determines the ability of the virus to replicate in the liver and cause hepatitis. I Virol 75: 2452–2457.
   Google Scholar
• Perlman S, Jacobsen G, Olson AL, Afifi A (1990). Identifi-cation of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus. Virology 175: 418–426.
   Google Scholar
• Phillips JJ, Chua MM, Lavi E, Weiss SR (1999). Pathogene-sis of chimeric MHV-4/MHV-A59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence. I Virol 73: 7752–7760.
   PubMed Web of Science ®Google Scholar
• Reed L, Muench H (1938). A simple method of estimating fifty percent end points. Am J Hyg 27: 493–497.
   Google Scholar
• Wege H, Siddell S, ter Meulen V (1982). The biology and pathogenesis of coronaviruses. Adv Virol Immunol 99: 165–200.
   Google Scholar
• Wege H, Stephenson JR, Koga M, Wege H, ter Meulen V (1981). Genetic variation of neurotropic and non-neurotropic murine coronaviruses. I Gen Virol 54: 67–74.
   Google Scholar
• Weiner LP (1973). Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus). Arch Neurol 28: 298–303.
   Google Scholar
• Yamada YK, Takimoto K, Yabe M, Taguchi F (1997). Ac-quired fusion activity of a murine coronavirus MHV-2 variant with mutations in the proteolytic cleavage site and the siganal sequence of the S protein. Virology 227: 215–219.
   Google Scholar
• Yokomori K, Banner LR, Lai MC (1991). Heteroginity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses. Virology 183: 647–657.
   Google Scholar